Sumatriptan (oral route of administration) for acute migraine attacks in adults-Reference-Cited by-同舟云学术

Sumatriptan (oral route of administration) for acute migraine attacks in adults

Published:2012-02-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Derry Christopher J¹,Derry Sheena²,Moore R Andrew³

Affiliation:

1. University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE

2. Oxford Oxfordshire UK

3. Plymouth UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference133 articles.

1. A multicentre, double-blind, placebo controlled, parallel group study of two dose levels of oral eletriptan and two dose levels of oral sumatriptan given for the acute treatment of migraine Pfizer clinical trial report 1998

2. Sumatriptan in the treatment of acute migraine with aura;Banerjee;Cephalalgia,1992

3. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial;Brandes;JAMA,2007

4. Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes;Landy;MedGenMed,2007

5. Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks;Bussone;Journal of the Neurological Sciences,2000

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glassy Carbon Electrode Modified with CB/TiO2 Layer for Sensitive Determination of Sumatriptan by Means of Voltammetry and Flow Injection Analysis;Sensors;2023-06-07

2. Selbstmedikation mit Triptanen bei Migräne;Schmerzmedizin;2023-03

3. Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials;Cephalalgia;2023-02

4. Self-Reported Breast Implant Illness: The Contribution of Systemic Illnesses and Other Factors to Patient Symptoms;Aesthetic Surgery Journal Open Forum;2023

5. Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm;The Clinical Journal of Pain;2022-09-26